Published in Cancer Res on April 01, 2000
Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest (2002) 4.05
Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest (2004) 3.90
Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology (2008) 2.99
The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities. Antioxid Redox Signal (2014) 2.26
Hypoxia: an alarm signal during intestinal inflammation. Nat Rev Gastroenterol Hepatol (2010) 2.18
Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PLoS One (2007) 1.77
Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome. Int J Radiat Oncol Biol Phys (2007) 1.55
Hypoxia and radiation therapy: past history, ongoing research, and future promise. Curr Mol Med (2009) 1.50
Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy. PLoS One (2009) 1.37
Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery. Annu Rev Physiol (2011) 1.36
Physiological and pathological responses to hypoxia. Am J Pathol (2004) 1.32
Hypoxia and metabolic factors that influence inflammatory bowel disease pathogenesis. Gastroenterology (2011) 1.26
Tumor oxygen dynamics: correlation of in vivo MRI with histological findings. Neoplasia (2003) 1.15
The distribution of the therapeutic monoclonal antibodies cetuximab and trastuzumab within solid tumors. BMC Cancer (2010) 1.14
The response of c-jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1 alpha dependent. Mol Cell Biol (2002) 1.12
Hypoxia and VEGF mRNA expression in human tumors. Neoplasia (2002) 1.06
Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms. ISRN Dermatol (2011) 1.05
Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation. Expert Opin Ther Targets (2009) 1.04
Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenografts. Eur J Nucl Med Mol Imaging (2008) 1.02
Ex vivo optical metabolic measurements from cultured tissue reflect in vivo tissue status. J Biomed Opt (2012) 0.99
New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting. Semin Oncol (2008) 0.98
The Relationship among Hypoxia, Proliferation, and Outcome in Patients with De Novo Glioblastoma: A Pilot Study. Transl Oncol (2010) 0.98
Multimodality imaging of hypoxia in preclinical settings. Q J Nucl Med Mol Imaging (2010) 0.98
Imaging hypoxia in orthotopic rat liver tumors with iodine 124-labeled iodoazomycin galactopyranoside PET. Radiology (2008) 0.97
Green fluorescent protein is a suitable reporter of tumor hypoxia despite an oxygen requirement for chromophore formation. Neoplasia (2002) 0.96
Pimonidazole binding in C6 rat brain glioma: relation with lipid droplet detection. Br J Cancer (2003) 0.96
NanoPET imaging of [(18)F]fluoromisonidazole uptake in experimental mouse tumours. Eur J Nucl Med Mol Imaging (2005) 0.95
Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors. Radiat Res (2008) 0.94
Elevated CAIX Expression is Associated with an Increased Risk of Distant Failure in Early-Stage Cervical Cancer. Biomark Insights (2008) 0.94
Clinical biomarkers for hypoxia targeting. Cancer Metastasis Rev (2008) 0.94
The inflammatory tissue microenvironment in IBD. Inflamm Bowel Dis (2013) 0.93
In vivo T cell activation in lymphoid tissues is inhibited in the oxygen-poor microenvironment. Front Immunol (2011) 0.90
Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimidazole tracer pimonidazole. Br J Cancer (2015) 0.88
Hypoxia and Mucosal Inflammation. Annu Rev Pathol (2016) 0.87
Hypoxia-selective DNA interstrand cross-link formation by two modified nucleosides. Chemistry (2012) 0.84
Hypoxia-induced autophagic response is associated with aggressive phenotype and elevated incidence of metastasis in orthotopic immunocompetent murine models of head and neck squamous cell carcinomas (HNSCC). Exp Mol Pathol (2011) 0.83
Hypoxia and Integrin-Mediated Epithelial Restitution during Mucosal Inflammation. Front Immunol (2013) 0.82
Optimizing hypoxia detection and treatment strategies. Semin Nucl Med (2015) 0.81
Identifying and targeting hypoxia in head and neck cancer: a brief overview of current approaches. Int J Radiat Oncol Biol Phys (2007) 0.81
Comparison of Helzel and OxyLite systems in the measurements of tumor partial oxygen pressure (pO2). Radiat Res (2008) 0.81
Oxygen sensing in intestinal mucosal inflammation. Pflugers Arch (2015) 0.76
Human esophageal cancer is distinguished from adjacent esophageal tissue by tissue cysteine concentrations. Dig Dis Sci (2002) 0.76
Hypoxia Inducible Factor (HIF) Hydroxylases as Regulators of Intestinal Epithelial Barrier Function. Cell Mol Gastroenterol Hepatol (2017) 0.75
18F-EF5 PET Is Predictive of Response to Fractionated Radiotherapy in Preclinical Tumor Models. PLoS One (2015) 0.75
Regulation of immunity and inflammation by hypoxia in immunological niches. Nat Rev Immunol (2017) 0.75
Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell (1995) 12.39
Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med (2001) 12.38
Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature (1998) 11.61
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature (1996) 10.14
Five intermediate complexes in transcription initiation by RNA polymerase II. Cell (1989) 9.22
Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys (1997) 8.58
Crystal structure of a yeast TBP/TATA-box complex. Nature (1993) 7.95
Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med (1996) 7.09
Reovirus messenger RNA contains a methylated, blocked 5'-terminal structure: m-7G(5')ppp(5')G-MpCp-. Proc Natl Acad Sci U S A (1975) 6.26
p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science (1995) 6.01
Ageing, fitness and neurocognitive function. Nature (1999) 5.58
Compulsory averaging of crowded orientation signals in human vision. Nat Neurosci (2001) 5.47
Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci U S A (1997) 5.44
An operator at -280 base pairs that is required for repression of araBAD operon promoter: addition of DNA helical turns between the operator and promoter cyclically hinders repression. Proc Natl Acad Sci U S A (1984) 5.42
Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science (1999) 5.15
p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev (1995) 4.87
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet (1999) 4.83
Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet (2001) 4.79
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood (1997) 4.78
Each of three "TATA elements" specifies a subset of the transcription initiation sites at the CYC-1 promoter of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1985) 4.69
Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol (2001) 4.56
Uncertainty in estimates of HIV/AIDS: the estimation and application of plausibility bounds. Sex Transm Infect (2004) 4.54
Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell (1995) 4.48
Vitellogenin in Xenopus laevis is encoded in a small family of genes. Cell (1979) 4.44
Activation of Arp2/3 complex-mediated actin polymerization by cortactin. Nat Cell Biol (2001) 4.38
Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A (1998) 3.99
Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology (2003) 3.99
Function of a yeast TATA element-binding protein in a mammalian transcription system. Nature (1988) 3.91
Diagnostic performance of amplified Mycobacterium tuberculosis direct test with cerebrospinal fluid, other nonrespiratory, and respiratory specimens. J Clin Microbiol (1996) 3.85
Direct detection of Mycobacterium tuberculosis complex in respiratory specimens by a target-amplified test system. J Clin Microbiol (1994) 3.81
Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate. J Clin Oncol (1998) 3.69
Reversibility of acute B-cell leukaemia induced by BCR-ABL1. Nat Genet (2000) 3.67
Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol (1988) 3.66
A transcription reinitiation intermediate that is stabilized by activator. Nature (2000) 3.65
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood (1997) 3.56
Crystal structure of the yeast TFIIA/TBP/DNA complex. Science (1996) 3.45
Mot1, a global repressor of RNA polymerase II transcription, inhibits TBP binding to DNA by an ATP-dependent mechanism. Genes Dev (1994) 3.45
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA (1999) 3.34
The impact of clean indoor-air laws and cigarette smuggling on demand for cigarettes: an empirical model. Health Econ (2000) 3.31
ACORN group, social class, and child health. J Epidemiol Community Health (1983) 3.27
Measuring social inequality: occupational classifications and their alternatives. Community Med (1983) 3.22
CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol (1998) 3.19
Methylated, blocked 5 termini in HeLa cell mRNA. Proc Natl Acad Sci U S A (1975) 3.02
The use of unequal randomisation ratios in clinical trials: a review. Contemp Clin Trials (2005) 2.98
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA (2001) 2.95
Intermediates in formation and activity of the RNA polymerase II preinitiation complex: holoenzyme recruitment and a postrecruitment role for the TATA box and TFIIB. Genes Dev (1999) 2.94
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin. J Clin Oncol (1991) 2.94
A yeast and a human CCAAT-binding protein have heterologous subunits that are functionally interchangeable. Cell (1988) 2.84
Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2-5. Circ Res (2000) 2.82
Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate. J Clin Oncol (2001) 2.81
Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc Natl Acad Sci U S A (1998) 2.80
Influence of subnarcotic doses of Althesin (CT1341) on pain induced by two types of pain stimulus. Br J Anaesth (1973) 2.77
Variants of the TATA-binding protein can distinguish subsets of RNA polymerase I, II, and III promoters. Cell (1992) 2.76
Nitrous oxide: time to stop laughing? Anaesthesia (1998) 2.75
Yeast HAP2 and HAP3 activators both bind to the CYC1 upstream activation site, UAS2, in an interdependent manner. Cell (1987) 2.73
Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood (2001) 2.73
The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev (1998) 2.72
Myocardial ischaemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet (1983) 2.70
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol (2013) 2.70
Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. Am J Epidemiol (2001) 2.69
The role of the TATA-binding protein in the assembly and function of the multisubunit yeast RNA polymerase III transcription factor, TFIIIB. Cell (1992) 2.69
Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat Genet (1997) 2.64
An evidence ontology for use in pathway/genome databases. Pac Symp Biocomput (2004) 2.63
Conducting a matched-pairs historical cohort study with a computer-based ambulatory medical record system. Comput Biomed Res (1990) 2.62
Reliability of skin involvement measures in scleroderma. The UK Scleroderma Study Group. Br J Rheumatol (1992) 2.58
Modular nature of abscisic acid (ABA) response complexes: composite promoter units that are necessary and sufficient for ABA induction of gene expression in barley. Plant Cell (1996) 2.56
The SF-36 health survey questionnaire: is it suitable for use with older adults? Age Ageing (1995) 2.54
Passive exposure to tobacco smoke: saliva cotinine concentrations in a representative population sample of non-smoking schoolchildren. Br Med J (Clin Res Ed) (1985) 2.51
Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology. Neurology (2012) 2.50
Novel thioether bond revealed by a 1.7 A crystal structure of galactose oxidase. Nature (1991) 2.48
Recruitment of the SWI/SNF chromatin remodeling complex by transcriptional activators. Genes Dev (1999) 2.48
The three-dimensional structure of a glutathione S-transferase from the mu gene class. Structural analysis of the binary complex of isoenzyme 3-3 and glutathione at 2.2-A resolution. Biochemistry (1992) 2.43
Conjugation of biomolecules with luminophore-doped silica nanoparticles for photostable biomarkers. Anal Chem (2001) 2.42
Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity. J Immunol (1994) 2.41
Vitellogenesis and the vitellogenin gene family. Science (1981) 2.39
A universal nucleoside for use at ambiguous sites in DNA primers. Nature (1994) 2.38
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study. HIV Med (2006) 2.38
Epidemiological link between exposure to poultry and all influenza A(H7N9) confirmed cases in Huzhou city, China, March to May 2013. Euro Surveill (2013) 2.34
Molecular characterization of Cryptosporidium isolates obtained from human immunodeficiency virus-infected individuals living in Switzerland, Kenya, and the United States. J Clin Microbiol (2000) 2.32
Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest (1997) 2.31
Growth Patterns Inferred from Anatomical Records : Empirical Tests Using Longisections of Roots of Zea mays L. Plant Physiol (1989) 2.31
Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut (2002) 2.29
Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol (1999) 2.25
Laparoscopic assisted live donor nephrectomy--a comparison with the open approach. Transplantation (1997) 2.23
Task coordination and aging: explorations of executive control processes in the task switching paradigm. Acta Psychol (Amst) (1999) 2.22
Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev (2000) 2.21
Why do mothers consult when their children cough? Fam Pract (1993) 2.21
An ATP-dependent inhibitor of TBP binding to DNA. Genes Dev (1993) 2.19
A yeast TFIIB-related factor involved in RNA polymerase III transcription. Genes Dev (1992) 2.17
Use of open standards to implement health maintenance guidelines in a clinical workstation. Comput Biol Med (1994) 2.15
Methyl labeling of HeLa cell hnRNA: a comparison with mRNA. Cell (1976) 2.13
Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study. Hepatology (2001) 2.13
The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis: results of a multicenter prospective trial. JAMA (2000) 2.12
Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis (1996) 2.12
Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax (2005) 2.08
[18F]-EF5, a marker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure. Appl Radiat Isot (2001) 2.08
The impact of chronic urticaria on the quality of life. Br J Dermatol (1997) 2.08